CBT
Bearish signalScored 2026-09-25 Drivers: trend, fundamentals. Moteurs : tendance, fondamentaux.
Research, not advice.
À propos
Cabot Corp.
- Nom
- Cabot Corp.
- Secteur
- Basic Materials
- Industrie
- Chemicals - Specialty
- Bourse
- NYSE
- Capitalisation
- $3.8B
- Employés
- 4,064
- PDG
- Erica J. McLaughlin
- Site web
- https://www.cabotcorp.com
- Marché
- AVNTCEFULHWKNKNFMEOH
Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through two segments, Reinforcement Materials and Performance Chemicals. The company offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions. It also provides specialty carbons for use in inks, coatings, plastics, adhesives, toners, batteries, and displays; conductive additives and fumed alumina used in lead acid and lithium-ion batteries for electric vehicles; fumed silica used in adhesives, sealants, cosmetics, batteries, inks, toners, silicone elastomers, coatings, polishing slurries, and pharmaceuticals; and fumed alumina for use in various products, including inkjet media, lighting, coatings, cosmetics, and polishing slurries. In addition, it offers aerogel, a hydrophobic, silica-based particle to use in various thermal insulation and specialty chemical applications; masterbatch and conductive compound products that are used in automotive, industrial, packaging, infrastructure, agriculture, consumer products, and electronics industries; and inkjet colorants for inkjet printing applications, as well as carbon nanotubes and fumed metal oxides. The company sells its products through distributors and sales representatives in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cabot Corporation was founded in 1882 and is headquartered in Boston, Massachusetts.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
VENTE TOTALE: 229 597 titres (~19 646 313,89 $ US)
- Insiders
- Keohane Sean D
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
$19,646,314
Avg sell (VWAP, 90d window) $85.57 vs last close $76.91 (-10.1%)
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
- Last activity
- 2026-08-28
- Liquidity
- Liquid $31,032,343/day · 20d vol
- Last synced
-
2026-09-30 21:10:13
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-08-28 | Keohane Sean D | Sell · S | 134,895 | $85.00 | $11,466,075 | Form 4 |
| 2026-08-24 | Keohane Sean D | Sell · S | 2,779 | $85.50 | $237,604 | Form 4 |
| 2026-08-07 | Keohane Sean D | Sell · S | 91,923 | $86.41 | $7,942,634 | Form 4 |
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Signal
Bearish signalScored 2026-09-25 Drivers: trend, fundamentals. Moteurs : tendance, fondamentaux.
CBT shows solid operational fundamentals with expanding margins and reduced leverage (liquidity score 70, fundamental trend score 75), but the event-driven signal is critically weak with a catalyst score of only 15 and…
The first sentence of the analysis written for CBT on 2026-09-25 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Narrative Pulls against a bullish reading. Stored narrative reading is in the bearish band
- Timing Pulls against a bullish reading. Close is more than 0.5 ATR under stored support
- Financial indicators Supports a bullish reading. Current ratio 1.61 · operating margin 17%
Suggested stop 75.16, nearest stored support minus 0.5 ATR(2.3% under the last close). Reward/risk to the next stored resistance is 2.42. Research, not advice. Not an order.
Market snapshot
Financial ratios
| Metric | Trend | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 25.3% | 24.0% | 21.3% | 20.5% | 23.4% | |
| Ebit Margin | 17.2% | 15.3% | 13.8% | 9.0% | 13.3% | |
| Ebitda Margin | 21.4% | 19.1% | 17.4% | 12.4% | 18.0% | |
| Operating Profit Margin | 16.7% | 15.4% | 13.4% | 9.0% | 13.3% | |
| Pretax Profit Margin | 15.4% | 13.4% | 11.6% | 8.0% | 12.0% | |
| Continuous Operations Profit Margin | 10.1% | 10.6% | 12.3% | 5.6% | 8.4% | |
| Net Profit Margin | 8.9% | 9.5% | 11.3% | 4.8% | 7.3% | |
| Bottom Line Profit Margin | 8.9% | 9.4% | 11.1% | 4.8% | 7.2% | |
| Current Ratio | 1.608 | 2.079 | 1.978 | 1.647 | 1.242 | |
| Quick Ratio | 1.082 | 1.364 | 1.266 | 1.046 | 0.786 | |
| Solvency Ratio | 0.230 | 0.247 | 0.268 | 0.142 | 0.185 | |
| Cash Ratio | 0.270 | 0.289 | 0.290 | 0.186 | 0.146 | |
| Price To Earnings Ratio | 12.529 | 16.461 | 8.892 | 17.504 | 11.495 | |
| Price To Earnings Growth Ratio | -1.182 | -1.282 | 0.078 | -1.075 | -0.055 | |
| Forward Price To Earnings Growth Ratio | -1.182 | -1.282 | 0.078 | -1.075 | -0.055 | |
| Price To Earnings Diluted Ratio | 12.633 | 16.632 | 8.961 | 17.649 | 11.548 | |
| Price To Earnings Diluted Growth Ratio | -1.213 | -1.273 | 0.079 | -1.064 | -0.055 | |
| Price To Book Ratio | 2.635 | 4.259 | 3.027 | 4.002 | 3.002 | |
| Price To Sales Ratio | 1.100 | 1.519 | 0.973 | 0.832 | 0.834 | |
| Price To Free Cash Flow Ratio | 10.445 | 13.456 | 10.902 | -32.376 | 45.857 | |
| Price To Operating Cash Flow Ratio | 6.141 | 8.770 | 6.431 | 35.937 | 11.063 | |
| Debt To Assets Ratio | 0.318 | 0.356 | 0.377 | 0.433 | 0.377 | |
| Debt To Equity Ratio | 0.784 | 0.933 | 1.076 | 1.699 | 1.316 | |
| Debt To Capital Ratio | 0.439 | 0.483 | 0.518 | 0.630 | 0.568 | |
| Long Term Debt To Capital Ratio | 0.356 | 0.447 | 0.464 | 0.548 | 0.431 | |
| Financial Leverage Ratio | 2.461 | 2.622 | 2.851 | 3.925 | 3.491 | |
| Working Capital Turnover Ratio | 5.248 | 4.880 | 5.176 | 8.703 | 9.378 | |
| Operating Cash Flow Ratio | 0.695 | 0.896 | 0.724 | 0.090 | 0.224 | |
| Operating Cash Flow Sales Ratio | 0.179 | 0.173 | 0.151 | 0.023 | 0.075 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.588 | 0.652 | 0.590 | -1.110 | 0.241 | |
| Debt Service Coverage Ratio | 1.709 | 4.392 | 2.621 | 1.061 | 0.996 | |
| Interest Coverage Ratio | 8.171 | 7.580 | 5.844 | 6.946 | 9.265 | |
| Short Term Operating Cash Flow Coverage Ratio | 2.427 | 10.328 | 3.269 | 0.282 | 0.578 | |
| Operating Cash Flow Coverage Ratio | 0.547 | 0.520 | 0.438 | 0.066 | 0.206 | |
| Capital Expenditure Coverage Ratio | 2.427 | 2.871 | 2.439 | 0.474 | 1.318 | |
| Dividend Paid And Capex Coverage Ratio | 1.797 | 2.072 | 1.792 | 0.339 | 0.935 | |
| Dividend Payout Ratio | 0.290 | 0.245 | 0.198 | 0.402 | 0.320 | |
| Enterprise Value Multiple | 6.349 | 9.429 | 7.224 | 9.150 | 6.376 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 25.3% | ▲1.3% | ▲2.4% |
| Ebit Margin | 17.2% | ▲2.0% | ▲3.5% |
| Ebitda Margin | 21.4% | ▲2.3% | ▲3.7% |
| Operating Profit Margin | 16.7% | ▲1.4% | ▲3.2% |
| Pretax Profit Margin | 15.4% | ▲2.0% | ▲3.3% |
| Continuous Operations Profit Margin | 10.1% | ▼-0.5% | ▲0.7% |
| Net Profit Margin | 8.9% | ▼-0.6% | ▲0.5% |
| Bottom Line Profit Margin | 8.9% | ▼-0.4% | ▲0.6% |
| Current Ratio | 1.608 | ▼-0.471 | ▼-0.103 |
| Quick Ratio | 1.081 | ▼-0.282 | ▼-0.027 |
| Solvency Ratio | 0.230 | ▼-0.018 | ▲0.015 |
| Cash Ratio | 0.270 | ▼-0.019 | ▲0.033 |
| Price To Earnings Ratio | 12.529 | ▼-3.932 | ▼-0.848 |
| Price To Earnings Growth Ratio | -1.181 | ▲0.101 | ▼-0.478 |
| Forward Price To Earnings Growth Ratio | -1.181 | ▲0.101 | ▼-0.478 |
| Price To Earnings Diluted Ratio | 12.633 | ▼-4.000 | ▼-0.852 |
| Price To Earnings Diluted Growth Ratio | -1.213 | ▲0.060 | ▼-0.508 |
| Price To Book Ratio | 2.635 | ▼-1.624 | ▼-0.750 |
| Price To Sales Ratio | 1.100 | ▼-0.420 | ▲0.048 |
| Price To Free Cash Flow Ratio | 10.445 | ▼-3.012 | ▲0.788 |
| Price To Operating Cash Flow Ratio | 6.141 | ▼-2.629 | ▼-7.527 |
| Debt To Assets Ratio | 0.319 | ▼-0.037 | ▼-0.054 |
| Debt To Equity Ratio | 0.784 | ▼-0.149 | ▼-0.378 |
| Debt To Capital Ratio | 0.439 | ▼-0.043 | ▼-0.088 |
| Long Term Debt To Capital Ratio | 0.356 | ▼-0.091 | ▼-0.093 |
| Financial Leverage Ratio | 2.461 | ▼-0.161 | ▼-0.609 |
| Working Capital Turnover Ratio | 5.248 | ▲0.368 | ▼-1.429 |
| Operating Cash Flow Ratio | 0.695 | ▼-0.202 | ▲0.169 |
| Operating Cash Flow Sales Ratio | 0.179 | ▲0.006 | ▲0.059 |
| Free Cash Flow Operating Cash Flow Ratio | 0.588 | ▼-0.064 | ▲0.396 |
| Debt Service Coverage Ratio | 1.709 | ▼-2.683 | ▼-0.447 |
| Interest Coverage Ratio | 8.171 | ▲0.591 | ▲0.610 |
| Short Term Operating Cash Flow Coverage Ratio | 2.427 | ▼-7.901 | ▼-0.950 |
| Operating Cash Flow Coverage Ratio | 0.547 | ▲0.027 | ▲0.192 |
| Capital Expenditure Coverage Ratio | 2.427 | ▼-0.444 | ▲0.521 |
| Dividend Paid And Capex Coverage Ratio | 1.797 | ▼-0.275 | ▲0.410 |
| Dividend Payout Ratio | 0.290 | ▲0.045 | ▼-0.001 |
| Enterprise Value Multiple | 6.349 | ▼-3.081 | ▼-1.357 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $4.08B | $6.07B | $3.83B | $3.59B | $2.84B | |
| Enterprise value | $5.04B | $7.18B | $4.95B | $4.91B | $3.92B | |
| EV / Sales | 1.36x | 1.80x | 1.26x | 1.14x | 1.15x | |
| EV / Op. cash flow | 7.58x | 10.37x | 8.32x | 49.14x | 15.26x | |
| EV / Free cash flow | 12.89x | 15.91x | 14.10x | -44.27x | 63.24x | |
| EV / EBITDA | 6.35x | 9.43x | 7.22x | 9.15x | 6.38x | |
| Net debt / EBITDA | 1.21x | 1.46x | 1.64x | 2.46x | 1.75x | |
| Current ratio | 1.61x | 2.08x | 1.98x | 1.65x | 1.24x | |
| Income quality | 1.77x | 1.63x | 1.23x | 0.41x | 0.90x | |
| Graham number | $63 | $64 | $64 | $37 | $41 | |
| Graham net-net | -$20 | -$20 | -$21 | -$24 | -$23 | |
| Tax burden | 57.9% | 71.0% | 97.6% | 60.6% | 61.1% | |
| Interest burden | 89.4% | 87.7% | 84.3% | 88.2% | 89.9% | |
| Working capital | $582.0M | $833.0M | $804.0M | $715.0M | $278.0M | |
| Invested capital | $2.48B | $2.55B | $2.41B | $2.18B | $1.89B | |
| Return on assets | 8.7% | 10.2% | 12.3% | 5.9% | 7.6% | |
| Operating ROA | 16.4% | 16.7% | 14.8% | 11.4% | 14.9% | |
| Return on tangible assets | 9.1% | 10.7% | 13.0% | 6.3% | 8.2% | |
| Return on equity | 21.4% | 26.7% | 35.2% | 23.3% | 26.4% | |
| Return on invested capital | 13.0% | 16.1% | 17.7% | 9.9% | 12.2% | |
| Return on capital employed | 21.7% | 20.7% | 18.9% | 16.1% | 21.0% | |
| Earnings yield | 8.1% | 6.3% | 11.6% | 5.8% | 8.8% | |
| Free cash flow yield | 9.6% | 7.4% | 9.2% | -3.1% | 2.2% | |
| Capex / Op. cash flow | 41.2% | 34.8% | 41.0% | 211.0% | 75.9% | |
| Capex / Depreciation | 177.9% | 159.6% | 169.4% | 144.5% | 121.9% | |
| Capex / Sales | 7.4% | 6.0% | 6.2% | 4.9% | 5.7% | |
| SG&A / Sales | 7.0% | 7.1% | 6.4% | 6.0% | 8.5% | |
| R&D / Sales | 1.6% | 1.6% | 1.5% | 1.3% | 1.6% | |
| Stock comp / Sales | 0.6% | 0.6% | 0.5% | 0.5% | 0.6% | |
| Intangibles / Total assets | 5.0% | 5.0% | 5.4% | 5.4% | 7.3% | |
| Days sales outstanding | 66d | 67d | 65d | 71d | 69d | |
| Days payables outstanding | 60d | 60d | 52d | 57d | 67d | |
| Operating cycle | 132d | 133d | 134d | 141d | 142d | |
| Cash conversion cycle | 72d | 74d | 82d | 85d | 75d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Recent news
- 2026-09-02 Why Is Cabot (CBT) Down 1.6% Since Last Earnings Report? Cabot (CBT) reported earnings 30 days ago. What''s next for the stock?
- 2026-09-02 Reasons Why You Should Retain Cabot Stock in Your Portfolio Now CBT is riding battery-materials growth, circular products and capacity expansion, even as weaker pricing and rising costs pressure profitability.
- 2026-08-12 Cabot Corporation Prices $350 Million 4.950% Senior Notes Due 2029 BOSTON, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE: CBT) today announced that it priced a public offering of $350 million of 4.950% senior unsecured notes due 2029. The notes are being sold to the public at a price of 99.993% of the face amount thereof.
- 2026-08-10 CBT Q3 Earnings Beat Estimates on Performance Chemicals Strength Cabot''s Q3 fiscal 2026 earnings beat estimates as Performance Chemicals gains offset Reinforcement Materials margin pressure.
- 2026-08-04 Cabot Q3 Earnings Call Highlights Cabot NYSE: CBT reported third-quarter fiscal 2026 adjusted earnings per share of $1.67, up 4% sequentially, as strength in its Performance Chemicals segment helped offset lower earnings in Reinforcement Materials.
- 2026-08-04 Cabot Corporation (CBT) Q3 2026 Earnings Call Transcript Cabot Corporation (CBT) Q3 2026 Earnings Call Transcript
- 2026-08-04 Cabot Corporation: Successful Returns, Downgrading Into 2027-2028E (Downgrade) Cabot Corporation is now fairly valued after a period of significant undervaluation and strong operational outperformance. I downgrade CBT to Hold with a new price target of $82/share, as the current upside is limited following a 20-30% rally. CBT''s disciplined capital allocation, low leverage, and resilient margins underpin its stability despite cyclical end-market pressures.
- 2026-08-03 Cabot (CBT) Tops Q3 Earnings and Revenue Estimates Cabot (CBT) came out with quarterly earnings of $1.67 per share, beating the Zacks Consensus Estimate of $1.66 per share. This compares to earnings of $1.9 per share a year ago.
- 2026-08-03 Cabot Corporation Reports Third Quarter Fiscal Year 2026 Results BOSTON, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE: CBT) today announced results for its third quarter fiscal year 2026. Third Quarter Highlights Third Quarter Diluted EPS of $0. 12 and Adjusted EPS of $1. 67 Reinforcement Materials segment EBIT of $97 million and Performance Chemicals segment EBIT of $68 million Battery Materials product line expanding global conductive additive capacity to support growing demand; reaffirming expectation of approximately $40 million of EBITDA for the full fiscal year Awarded Platinum rating from EcoVadis for exceptional leadership in sustainability performance for the sixth consecutive year Announced a planned leadership transition, with Erica McLaughlin elected to succeed Sean Keohane as President and CEO and a member of Cabot''s Board of Directors, all effective October 1, 2026 Sean Keohane, Cabot President and Chief Executive Officer, commented: "I am pleased with our strong third-quarter performance as our teams continued to execute at a high level despite a dynamic operating environment.
- 2026-08-03 Cabot Corporation Reports Third Quarter Fiscal Year 2026 Results BOSTON, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE: CBT) today announced results for its third quarter fiscal year 2026. Third Quarter Highlights Third Quarter Diluted EPS of $0.12 and Adjusted EPS of $1.67 Reinforcement Materials segment EBIT of $97 million and Performance Chemicals segment EBIT of $68 million Battery Materials product line expanding global conductive additive capacity to support growing demand; reaffirming expectation of approximately $40 million of EBITDA for the full fiscal year Awarded Platinum rating from EcoVadis for exceptional leadership in sustainability performance for the sixth consecutive year Announced a planned leadership transition, with Erica McLaughlin elected to succeed Sean Keohane as President and CEO and a member of Cabot''s Board of Directors, all effective October 1, 2026 (In millions, except per share amounts) Three Months Ended Nine Months Ended 6/30/26 6/30/25 6/30/26 6/30/25 Net sales and other operating revenues $ 982 $ 923 $ 2,735 $ 2,814 Net income (loss) attributable to Cabot Corporation $ 6 $ 101 $ 147 $ 288 Net earnings (loss) per share attributable to Cabot Corporation $ 0.12 $ 1.86 $ 2.77 $ 5.22 Less: Certain items after tax per share $ (1.55 ) $ (0.04 ) $ (2.05 ) $ (0.34 ) Adjusted EPS $ 1.67 $ 1.90 $ 4.82 $ 5.56 Sean Keohane, Cabot President and Chief Executive Officer, commented: “I am pleased with our strong third-quarter performance as our teams continued to execute at a high level despite a dynamic operating environment.